Funding fix: How new funding models are helping biotech startups launch

In the early 2000s, the process of forming a biotech company would typically go something like this: A scientist would discover or develop a novel asset, decide to form a company around it, then go about finding external funding and eventually build out the firm. Over the past two decades, the model has shifted.